Ursodeoxycholic Acid Market Projections of Trends and Growth till 2026

Ursodeoxycholic Acid Market – Size, Share, Outlook, and Opportunity Analysis 2018 - 2026
 
 
Spread the Word
Listed Under

Tag:
Ursodeoxycholic Acid

Industry:
Health

Location:
Seattle - Washington - US

Subject:
Reports

SEATTLE - July 18, 2019 - PRLog -- rsodeoxycholic acid (UDCA) is a bile acid taken as either a tablet or liquid to treat gallstones and to treat and prevent progression of cystic fibrosis-related liver disorders. UDCA modifies the bile acid pool by decreasing levels of hydrophobic bile acids while increasing proportion of nontoxic hydrophilic bile acids. UDCA can delay development of gastroesophageal varices and progression to cirrhosis. Moreover, it can improve long-term survival in patients with primary biliary cirrhosis.

Significant improvement in liver health can be achieved through UDCA therapy in patients with intrahepatic cholestasis of pregnancy, primary sclerosing cholangitis, nonalcoholic fatty liver disease, cystic fibrosis-associated liver disease, total parenteral nutrition-induced cholestasis, graft related liver disease, and in some pediatric cholestatic liver diseases.

The global ursodeoxycholic acid market size was valued at US$ 457.3 million in 2017 and is expected to exhibit a CAGR of 10.1% over the forecast period (2018 – 2026).

Request Free Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/2199

Ursodeoxycholic acid is being increasingly used for treatment of chronic cholestatic liver diseases. Increasing prevalence of cystic fibrosis and gall stones is the major factor driving growth of the global ursodeoxycholic acid market during the forecast period. According to the Cystic Fibrosis Foundation 2015 data, around 30,000 people suffered from cystic fibrosis in the U.S. Moreover, around 1,000 new cases of cystic fibrosis are diagnosed in the country, annually. According to the American Gastroenterological Association 2017 report, gallstones is affecting 10-15% of the U.S. population annually, which accounts for around 25 million people.

Get Full Access of This Business Report: https://www.coherentmarketinsights.com/market-insight/ursodeoxycholic-acid-market-2199

Key Players

Major players operating in the global ursodeoxycholic acid market include Dipharma Francis Srl, ERREGIERRE S.p.A., Grindeks, Industria Chimica Emiliana, Mitsubishi Tanabe Pharma Corporation, Zhongshan Belling Biotechnology Co., Glenmark Pharmaceutical Limited, Abil Chempharma Private Limited, Biotavia Labs Pvt Ltd, Daewoong Bio Inc., PharmaZell GmbH, and Suzhou Tianlu Bio-pharmaceutical Co., Ltd.

Detailed Segmentation:

Global Ursodeoxycholic Acid Market, By Dosage Form:

• Solid Dosage Form
• Liquid Dosage Form

Global Ursodeoxycholic Acid Market, By Mode of Extraction:

• Synthetic
• Biological

Global Ursodeoxycholic Acid Market, By Application:

• Gallstones
• Cystic Fibrosis
• Liver Cirrhosis
• Others

Purchase Report Here: https://www.coherentmarketinsights.com/insight/buy-now/2199

About Coherent Market Insights:


Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

End
Email:***@coherentmarketinsights.com
Posted By:***@coherentmarketinsights.com Email Verified
Tags:Ursodeoxycholic Acid
Industry:Health
Location:Seattle - Washington - United States
Subject:Reports
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse



Like PRLog?
9K2K1K
Click to Share